Affiliation:
1. Departamento de Química Orgánica Facultad de Ciencias Exactas y Naturales Universidad de Buenos Aires Ciudad Universitaria, Pabellón 2 C1428EHA Buenos Aires Argentina
2. CONICET-Universidad de Buenos Aires Centro de Investigaciones en Hidratos de Carbono (CIHIDECAR) C1428EHA Buenos Aires Argentina
3. CONICET-Universidad de Buenos Aires Unidad de Microanálisis y Métodos Físicos en Química Orgánica (UMYMFOR) C1428EHA Buenos Aires Argentina
Abstract
AbstractThe chemical and biological interest in this element and the molecules bearing selenium has been exponentially growing over the years. Selenium, formerly designated as a toxin, becomes a vital trace element for life that appears as selenocysteine and its dimeric form, selenocystine, in the active sites of selenoproteins, which catalyze a wide variety of reactions, including the detoxification of reactive oxygen species and modulation of redox activities. From the point of view of drug developments, organoselenium drugs are isosteres of sulfur‐containing and oxygen‐containing drugs with the advantage that the presence of the selenium atom confers antioxidant properties and high lipophilicity, which would increase cell membrane permeation leading to better oral bioavailability. This statement is the paramount relevance considering the big number of clinically employed compounds bearing sulfur or oxygen atoms in their structures including nucleosides and carbohydrates. Thus, in this article we have focused on the relevant features of the application of selenium in medicinal chemistry. With the increasing interest in selenium chemistry, we have attempted to highlight the most significant published data on this subject, mainly concentrating the analysis on the last years. In consequence, the recent advances of relevant pharmacological organoselenium compounds are discussed.
Funder
Universidad de Buenos Aires
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献